UnitedHealth Group earlier Tuesday suspended its earnings guidance for 2025, prompting investors to pull back on shares of the company and other names in the healthcare space.

Shares of UnitedHealth Group tumbled nearly 18% on Tuesday, erasing more than $67 billion in market value, after the ...

Key Takeaways The S&P 500 rose 3.3% on Monday, May 12, 2025, as investors reviewed a trade deal between the U.S. and China ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

Healthcare services represented a smaller share of operating income at ... a consulting company. Cigna, Aetna parent company CVS Health and Elevance Health have been increasing specialty pharmacy ...

Witty will act as a senior advisor to his successor, Stephen Hemsley, who served as UnitedHealth Group's CEO from 2006 to ...

Buffett, whose Berkshire Hathaway will host its annual meeting this Saturday, has held his tongue on what Trump's tariffs mean for economies and markets. "Black in Business," one program in the effort ...

The sharp decline erased tens of billions in market value and rippled ... The revised outlook triggered a broad selloff across the sector, with shares of Cigna, CVS Health, Elevance, Centene, and ...

UnitedHealth Group shares plunged in premarket trading as the firm announced a surprise exit of the current CEO and pulled its full-year forecast.

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.